Results 21 to 30 of about 7,578 (214)
New diagnostic criteria for CVID [PDF]
Expert Review of Clinical Immunology, 2014 RESPONSE TO: Kumar R, Bhatia A. Common variable immunodeficiency in adults: current diagnostic protocol and laboratory measures. Expert Rev. Clin. Immunol. 10(2), 000-000 (2014).Rohan, Ameratunga, See-Tarn, Woon, David, Gillis, Wikke, Koopmans, Richard, Steele +4 moreopenaire +2 more sourcesCVID-associated TACI mutations affect autoreactive B cell selection and activation [PDF]
, 2013 Common variable immune deficiency (CVID) is an assorted group of primary diseases that clinically manifest with antibody deficiency, infection susceptibility, and autoimmunity.Tuure Kinnunen, Gentile, M, Cantaert, T, Tineke Cantaert, Menard, L, Laurence Menard, Morbach, H, Saadoun, D, Virdee, M, Neil Romberg, Kinnunen, T, Maurizio Gentile, Rachid, R, Martinez-Pomar, N, Geha, R, Henner Morbach, Matamoros, N, Cunningham-Rundles, C, Nicolas Chamberlain, Nuria Matamoros, Andrea Cerutti, Yen Shing Ng, Bodo Grimbacher, Natalia Martinez-Pomar, Meffre, E, Eric Meffre, David Saadoun, Manmeet Virdee, Rima Rachid, Cerutti, A, Raif Geha, Romberg, N, Brimbacher, B, Chamberlain, N, Charlotte Cunningham-Rundles, Ng, YS +35 morecore +1 more sourceScreening of functional and positional candidate genes in families with common variable immunodeficiency [PDF]
, 2008 Background: Common variable immunodeficiency (CVID) comprises a heterogeneous group of primary antibody deficiencies with complex clinical and immunological phenotypes.Grimbacher, B, Thiel, J, Jung, J, Webster, A. David B., Webster, D, Schäffer, Alejandro A., Pan Hammarström, Q, Lougaris, V, Hammarström, L, Salzer, U, Hagena, Tina, Grimbacher, B., Jung, Johannes, Woellner, Cristina, MOSCHESE, VIVIANA, Schaffer, AA, Webster, DA, Birmelin, J, Pan-Hammarström, Qiang, Du, Likun, Schäffer, A, Birmelin, Jennifer, Woellner, C, Neumann, C, Salzer, Ulrich, Metin, A, Lougaris, Vassilios, Plebani, Alessandro, Hagena, T, Grimbacher, Bodo, Pan-Hammarstrom, Q, Du, L, Thiel, Jens, Hammarström, Lennart, Moschese, V, Hammarstroo, L, Metin, Ayse, Plebani, A, Neumann, Carla +38 morecore +1 more sourceUnexpectedly High Prevalence of Common Variable Immunodeficiency in Finland
Frontiers in Immunology, 2017 BackgroundCommon variable immunodeficiency (CVID) is the most common primary immunodeficiency. Prevalence varies greatly between countries and studies.Jannica S. Selenius, Jannica S. Selenius, Timi Martelius, Sampsa Pikkarainen, Sanna Siitonen, Eero Mattila, Risto Pietikäinen, Pekka Suomalainen, Arja H. Aalto, Arja H. Aalto, Janna Saarela, Elisabet Einarsdottir, Elisabet Einarsdottir, Elisabet Einarsdottir, Asko Järvinen, Martti Färkkilä, Juha Kere, Juha Kere, Juha Kere, Juha Kere, Mikko Seppänen, Mikko Seppänen +21 moredoaj +1 more sourceiNKT cells are reduced in CVID. [PDF]
, 2013 (A) Representative staining illustrating the gating strategy used. (B) Comparison between the frequency of iNKT cells in healthy control subjects and CVID patients before IVIg (left panel), and in CVID patients before and after IVIg (right panel).Jorge Kalil (52916), Markus Moll (109640), Cristina M. Kokron (468576), Dominic Paquin-Proulx (468572), Bianca A. N. Santos (468573), Karina I. Carvalho (244966), Ana Karolina Barreto de Oliveira (468575), Johan K. Sandberg (353026), Myrthes Toledo-Barros (468574), Esper G. Kallas (36139) +9 morecore +1 more sourceDysregulated PI3K Signaling in B Cells of CVID Patients [PDF]
, 2022 The altered wiring of signaling pathways downstream of antigen receptors of T and B cells contributes to the dysregulation of the adaptive immune system, potentially causing immunodeficiency and autoimmunity.Wienands, Jürgen; 3Institute of Cellular and Molecular Immunology, University Medical Center Göttingen, Göttingen, Germany; matthias.muenchhalfen@med.uni-goettingen.de (M.M.); jwienan@gwdg.de (J.W.), Warnatz, Klaus, Maccari, Maria Elena, Boerries, Melanie, Andrieux, Geoffroy; 4Institute of Medical Bioinformatics and Systems Medicine, Medical Center—University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; geoffroy.andrieux@uniklinik-freiburg.de (G.A.); melanie.boerries@uniklinik-freiburg.de (M.B.), Ehl, Stephan, Grimbacher, Bodo; 6Institute for Immunodeficiency, Center for Chronic Immunodeficiency (CCI), Medical Center, Faculty of Medicine, Albert-Ludwigs-University of Freiburg, Freiburg, Germany; bodo.grimbacher@uniklinik-freiburg.de (B.G.); maria.elena.maccari@uniklinik-freiburg.de (M.E.M.); stephan.ehl@uniklinik-freiburg.de (S.E.), Eibel, Hermann, Ehl, Stephan; 6Institute for Immunodeficiency, Center for Chronic Immunodeficiency (CCI), Medical Center, Faculty of Medicine, Albert-Ludwigs-University of Freiburg, Freiburg, Germany; bodo.grimbacher@uniklinik-freiburg.de (B.G.); maria.elena.maccari@uniklinik-freiburg.de (M.E.M.); stephan.ehl@uniklinik-freiburg.de (S.E.), Andrieux, Geoffroy, Münchhalfen, Matthias; 3Institute of Cellular and Molecular Immunology, University Medical Center Göttingen, Göttingen, Germany; matthias.muenchhalfen@med.uni-goettingen.de (M.M.); jwienan@gwdg.de (J.W.), Jellusova, Julia; 12Institute of Clinical Chemistry and Pathobiochemistry, School of Medicine, Klinikum Rechts der Isar, Technical University of Munich, 81675 Munich, Germany; julia.jellusova@tum.de, Wienands, Jürgen, Jellusova, Julia, Grimbacher, Bodo, Harder, Ina; 1Department of Rheumatology and Clinical Immunology, Medical Center—University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; ina.harder@uniklinik-freiburg.de (I.H.); hermann.eibel@uniklinik-freiburg.de (H.E.), Eibel, Hermann; 1Department of Rheumatology and Clinical Immunology, Medical Center—University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; ina.harder@uniklinik-freiburg.de (I.H.); hermann.eibel@uniklinik-freiburg.de (H.E.), Münchhalfen, Matthias, Maccari, Maria Elena; 6Institute for Immunodeficiency, Center for Chronic Immunodeficiency (CCI), Medical Center, Faculty of Medicine, Albert-Ludwigs-University of Freiburg, Freiburg, Germany; bodo.grimbacher@uniklinik-freiburg.de (B.G.); maria.elena.maccari@uniklinik-freiburg.de (M.E.M.); stephan.ehl@uniklinik-freiburg.de (S.E.), Keller, Baerbel; 1Department of Rheumatology and Clinical Immunology, Medical Center—University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; ina.harder@uniklinik-freiburg.de (I.H.); hermann.eibel@uniklinik-freiburg.de (H.E.), Keller, Baerbel, Warnatz, Klaus; 1Department of Rheumatology and Clinical Immunology, Medical Center—University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; ina.harder@uniklinik-freiburg.de (I.H.); hermann.eibel@uniklinik-freiburg.de (H.E.), Harder, Ina, Boerries, Melanie; 4Institute of Medical Bioinformatics and Systems Medicine, Medical Center—University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; geoffroy.andrieux@uniklinik-freiburg.de (G.A.); melanie.boerries@uniklinik-freiburg.de (M.B.) +23 morecore +3 more sources